Remove ads
Benzgalantamine, sold under the brand name Zunveyl, is a medication used for the treatment of mild to moderate dementia of the Alzheimer's type.[1] It is a cholinesterase inhibitor.[1] Benzgalantamine is a prodrug of galantamine.[1]
 | |
| Clinical data | |
|---|---|
| Trade names | Zunveyl |
| Other names | ALPHA-1062 |
| AHFS/Drugs.com | Zunveyl |
| License data | |
| Routes of administration | By mouth |
| Drug class | Cholinesterase inhibitor |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C24H25NO4 |
| Molar mass | 391.467 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.[1]
Benzgalantamine was approved for medical use in the United States in July 2024.[1][2][3]
Benzgalantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.[1][2]
The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.[1]
Legal status
Benzgalantamine was approved for medical use in the United States in July 2024.[1][2]
Names
Benzgalantamine is the international nonproprietary name.[4]
Wikiwand in your browser!
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.
Remove ads